Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Psoriasis: HELP
Stephen K. Tyring
Based on 31 articles published since 2008
||||
Expertise Level
The expertise of Stephen K. Tyring ranks in the
  • Top 0.36%
  • ... of 37,573 published authors worldwide on Psoriasis
  • ... from 2008 through 2019
  • ... based on contributions to 31 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Tyring, Steve   ·   Tyring, Stephen K   ·   Tyring, Stephen   ·   Tyring, S K   ·   Tyring, S
Work Locations
Details
Most likely:    University of Texas Houston   Contact    
2017
  • Center For Clinical Studies, Houston, TX, USA. · Texas Tech School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA. · Baylor College of Medicine, Houston, TX, USA. · Center For Clinical Studies, Houston, TX, USA; Department of Dermatology, University of California San Diego, La Jolla, CA, USA. · Department of Dermatology, University of Texas Health Science Center, Houston, TX, USA. · Pubmed 28329405
  • Center for Clinical Studies, Houston, TX, USA; Department of Dermatology, University of California San Diego, La Jolla, CA, USA. · Center for Clinical Studies, Houston, TX, USA. · Center for Clinical Studies, Houston, TX, USA; Department of Dermatology, The University of Texas Health Science Center at Houston, Houston, TX, USA. · Pubmed 28122092
  • Oregon Medical Research Center, Portland, OR, USA. · Dermatologikum Hamburg and SCIderm GmbH, Hamburg, Germany. · NorthShore University Health System, Skokie, IL, USA. · Dermatology Department, Hospital Universitario, Madrid, Spain. · Department of Medicine (Dermatology) UCLA, Los Angeles, CA, USA. · Baylor University Medical Center, Dallas, TX, USA. · Formerly with Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Novartis Pharma AG, Basel, Switzerland. · RTI Health Solutions, Research Triangle Park, NC, USA. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · University of Texas Health Science Center for Clinical Studies, Houston, TX, USA. · Pubmed 28602039
  • SCIderm Research Institute and Dermatologikum Hamburg, Hamburg, Germany. Electronic address: · Probity Medical Research, Waterloo, ON, Canada. · Oregon Medical Research Center, Portland, OR, USA. · Department of Dermatology, University of Texas Health Science Center, Houston, TX, USA. · Epworth Hospital Department of Dermatology, University of Melbourne, Melbourne, VIC, Australia. · Comprehensive Center for Inflammation Medicine, University Medical School Schleswig-Holstein, University of Lübeck, Lübeck, Germany. · Merck & Co, Kenilworth, NJ, USA. · Harvard Medical School, Boston, MA, USA. · Pubmed 28596043
  • From K. Papp Clinical Research and Probity Medical Research, Waterloo, ON (K.A.P.), School of Medicine, Queen's University, Kingston, ON (M.G.), and Centre for Dermatology and Probity Medical Research, Peterborough, ON (M.G.) - all in Canada · Oregon Medical Research Center, Portland (A.B.) · Altman Dermatology Associates, Arlington Heights, IL (M.B.) · Rockefeller University, New York (J.K.) · Hôpital de l'Archet, University of Nice-Sophia Antipolis, Nice, France (J.-P.L.) · Baylor Research Institute, Dallas (A.M.) · Charité Universitätsmedizin Berlin, Berlin (S.P.), Boehringer Ingelheim Pharma, Biberach (B.R.B.), and Boehringer Ingelheim Pharma, Ingelheim, (S.J.P.) - all in Germany · University of Texas Health Science Center, Houston (S.T.) · University of California, Los Angeles, School of Medicine, Los Angeles (H.S.) · and Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (S.V., C.P., N.B., M.F., P.S.). · Pubmed 28423301
  • Psoriasis Treatment Center of Central New Jersey, East Windsor, NJ, U.S.A. · University of Texas Health Science Center and Center for Clinical Studies, Houston, TX, U.S.A. · Amgen Inc., Thousand Oaks, CA, U.S.A. · Probity Medical Research, Ontario, Canada. · Pubmed 28196270
  • a University Hospitals Cleveland Medical Center , Cleveland , OH , USA. · b Department of Medicine/Dermatology , University of California at Los Angeles , Los Angeles , CA , USA. · c Dawes Fretzin Dermatology Group , Indianapolis , IN , USA. · d Oregon Dermatology and Research Center , Portland , OR , USA. · e Novartis Pharmaceuticals Corporation , One Health Plaza , East Hanover , NJ , USA. · f RTI Health Solutions , Research Triangle Park , NC , USA. · g RTI Health Solutions , Ann Arbor , MI , USA. · h Department of Dermatology , University of Texas Health Science Center , Houston , TX , USA. · Pubmed 27832717
  • Oregon Medical Research Center, Portland, Oregon. Electronic address: · Dermatologikum Hamburg and SCIderm Research Institute, Hamburg, Germany. · National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. · University of Texas Health Science Center at Houston, Center for Clinical Studies, Houston, Texas. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Dermatology Clinic, Tartu University Hospital, Tartu, Estonia. · Emek Medical Center, Afula, Israel. · Goethe Universität Frankfurt am Main, Frankfurt, Germany. · McMaster University, Hamilton, Ontario, Canada. · Novartis Pharma AG, Basel, Switzerland. · Novartis Beijing Novartis Pharma Co. Ltd, Shanghai, China. · Comprehensive Center for Inflammation Medicine, University Hospital Schleswig-Holstein, Lübeck, Germany. · Pubmed 27663079
  • Oregon Health and Science University, Portland, Oregon. Electronic address: · Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York. · Department of Quality Measures and Research, Clalit Health Services, Tel Aviv, Israel; Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel. · University of Texas Health Science Center, Houston, Texas. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, Collegeville, Pennsylvania. · Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Hellerup, Denmark. · Pfizer Inc, New York, New York. · Pubmed 28711084
  • Oregon Medical Research Center, Portland, OR, U.S.A. · Dermatologikum Hamburg and SCIderm Research Institute, Hamburg, Germany. · The Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, U.K. · Department of Dermatology, Venereology, and Allergology, Wroclaw Medical University, Wroclaw, Poland. · Department of Dermatology, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · University of Texas Health Science Center at Houston and Center for Clinical Studies, Houston, TX, U.S.A. · Novartis Pharma AG, Basel, Switzerland. · Novartis Healthcare Pvt. Ltd, Hyderabad, India. · Dalhousie University, Halifax, NS, Canada. · Pubmed 28498514
2016
  • Center for Clinical Studies, Houston, TX, USA. · Baylor College of Medicine, Houston, TX, USA. · Department of Dermatology, University of California San Diego, San Diego, CA, USA. · Department of Dermatology, University of Texas Health Science Center at Houston, Houston, TX, USA. · Center for Clinical Studies, Houston, TX, USA; Department of Dermatology, University of Texas Health Science Center at Houston, Houston, TX, USA. · Pubmed 27825174
  • a Department of Dermatology , University of California , San Francisco , San Francisco , CA , USA . · b Department of Dermatology , University of Texas Health Science Center , Houston , TX , USA . · c University of Washington School of Medicine , Seattle , WA , USA . · d Suzanne Bruce and Associates, PA , Houston , TX , USA . · e LEO Pharma A/S , Ballerup , Denmark , and. · f Psoriasis Treatment Center of Central New Jersey , East Windsor , NJ , USA. · Pubmed 26444907
  • Probity Medical Research and K. Papp Clinical Research Inc, Waterloo, Ontario, Canada. · Rockefeller University, New York, New York. · Wake Forest Baptist Health, Winston-Salem, North Carolina. · Dalhousie University, Halifax, Nova Scotia, Canada. · Comprehensive Center for Inflammation Research, University Hospital Schleswig-Holstein Campus Lübeck, Lübeck, Germany. · Division of Dermatology, Tokyo Yamate Medical Center, Tokyo, Japan. · Department of Dermatology, University of Texas Medical School, Houston, Texas. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, Cambridge, Massachusetts. · Dermatology Unit, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. · Pfizer Inc, Groton, Connecticut. Electronic address: · Pubmed 26899199
2015
  • Department of Dermatology, University of Maryland Medical Center, Baltimore, Maryland. · Department of Dermatology, University of Texas Health Science Center, Houston, Texas. · Pubmed 26201310
  • From the Icahn School of Medicine at Mount Sinai, New York (M.L., L.K.) · University of Connecticut School of Medicine, Farmington (B.S.) · Probity Medical Research (B.S., L.S., D.T.) and XLR8 Medical Research (D.T.), Windsor, ON, K Papp Medical Research (K.P.), Waterloo, ON, and Dalhousie University, Halifax, NS (R.G.L.) - all in Canada · Baylor University Medical Center, Dallas (A.M.) · Northwestern University, Feinberg School of Medicine, Chicago (K.G.) · Niepubliczny Zakład Opieki Zdrowotnej multiMedica, Wrocław (J.W.), and Lubelskie Centrum Diagnostyczne, Świdnik (T.B.) - both in Poland · Hospital de la Santa Creu i Sant Pau, Barcelona (L.P.) · Veracity Clinical Research, Woolloongabba, QLD, Australia (L.S.) · Florida Academic Dermatology Center, Miami (F.K.) · University of Colorado, Denver (A.W.A.) · Medizinische Universität Wien, Vienna, Austria (G.S.) · Massachusetts General Hospital and Harvard Medical School, Boston (A.B.K.) · Sorbonne Paris Cité Université Paris Diderot, Assistance Publique-Hôpitaux de Paris Hôpital Saint Louis, Paris (H.B.), Paul Sabatier University, Toulouse (C.P.), and University Hospital of Nice, Nice (J.-P.L.) - all in France · Kaiser Permanente Los Angeles Medical Center, Los Angeles (J.J.W.), Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield (J.C.), University of California, San Francisco, San Francisco (J.K.), and Amgen, Thousand Oaks (G.A., J.L., W.S., C.E.M., Y.S., N.E., P.K., B.K., A.N.) - all in California. · University of Texas Health Science Center, Houston (S.T.) · DermResearch, Louisville, KY (L.K.) · University of Rome Tor Vergata, Rome (S.C.) · University of Utah Medical Center, Salt Lake City (K.C.D.) · and the Psoriasis Treatment Center of Central New Jersey, East Windsor (J.B.). · Pubmed 26422722
  • Department of Dermatology, Faculty of Medicine, University of Chile and Probity Medical Research, Santiago, Chile. · Clinical Research and Probity Medical Research, Waterloo, ON, Canada. · Department of Dermatology, Eastern Virginia Medical School and Virginia Clinical Research Inc., Norfolk, VA, USA. · Department of Dermatology, University of Texas Medical School, Houston, TX, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, Groton, CT, USA. · Quintiles, Cambridge, MA, USA. · Present address: Statistical Consulting & Solutions, LLC, Brookline, MA, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, New York, NY, USA. · Specialty Care Medicines Development Group, Pfizer Inc, 219 E 42nd Street, 7th Floor Room 50, NYO 219/07/01, New York, NY, 10017, USA. · Pubmed 25951857
2014
  • From Dalhousie University, Halifax, NS (R.G.L.), Clinical Research (K.P.) and Probity Medical Research (K.P., L.S.), Waterloo, ON, and Stratica Medical and Probity Medical Research, Edmonton, AB (N.W.) - all in Canada · University of Alabama, Birmingham (B.E.E.) · Mount Sinai Hospital, New York (M.L.) · Dermatologikum Hamburg and Georg-August-Universität, Göttingen, Germany (K.R.) · Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom (C.E.M.G.) · Hospital de Sant Pau, Barcelona (L.P.) · Jikei University School of Medicine, Tokyo (H.N.) · Veracity Clinical Research, Woolloongabba, QLD, Australia (L.S.) · Faculty of Medicine, Department of Dermatology, University of Iceland, Reykjavik (B.S.) · Dermos, Guatemala City, Guatemala (E.R.) · Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei (T.-F.T.) · University of Texas Health Science Center and Center for Clinical Studies, Houston (S.T.) · and Novartis Pharma, Basel, Switzerland (T.S., I.H., M.N., A.K., S.H., C.P.). · Pubmed 25007392
2010
  • Center for Clinical Studies, Department of Dermatology, University of Texas Health Science Center, Houston, TX, USA. · Pubmed 20964660
2008
  • Center for Clinical Studies and Department of Dermatology, University of Texas Health Science Center, Houston, TX 77030, USA. · Pubmed 18486724
Probable:    Miscellaneous institutions in Houston      
2015
  • Center for Clinical Studies, Houston, TX, USA. · Department of Dermatology, University of Texas Health Science Center at Houston, Houston, TX, USA. · Pubmed 25807335
2013
2008
  • Center for Clinical Studies, 6655 Travis #120, Houston, TX 77030, USA. · Pubmed 18363545
  • Center for Clinical Studies, Houston, TX, USA. · Pubmed 19145382
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 31 total) written by Stephen K. Tyring about Psoriasis:

  • A Review of Guselkumab, an IL-23 Inhibitor, for Moderate-to-Severe Plaque Psoriasis. 2017
  • A Review of Brodalumab, an IL-17 Receptor Antagonist, for Moderate-to-Severe Plaque Psoriasis. 2017
  • Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate-to-severe plaque psoriasis: 52-week results from the CLEAR study. 2017
  • Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials. 2017
  • Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis. 2017
  • Open-label study of etanercept treatment in patients with moderate-to-severe plaque psoriasis who lost a satisfactory response to adalimumab. 2017
  • Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasis. 2017
  • Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study. 2017
  • Herpes zoster in psoriasis patients treated with tofacitinib. 2017
  • Secukinumab re-initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis. 2017
Show List of Full Article Records
Google Searches

Learn more about Stephen K. Tyring using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Texas Houston
Miscellaneous institutions in Houston
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Texas Houston
2017
  • Center For Clinical Studies, Houston, TX, USA. · Texas Tech School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA. · Baylor College of Medicine, Houston, TX, USA. · Center For Clinical Studies, Houston, TX, USA; Department of Dermatology, University of California San Diego, La Jolla, CA, USA. · Department of Dermatology, University of Texas Health Science Center, Houston, TX, USA. · Pubmed 28329405
  • Center for Clinical Studies, Houston, TX, USA; Department of Dermatology, University of California San Diego, La Jolla, CA, USA. · Center for Clinical Studies, Houston, TX, USA. · Center for Clinical Studies, Houston, TX, USA; Department of Dermatology, The University of Texas Health Science Center at Houston, Houston, TX, USA. · Pubmed 28122092
  • Oregon Medical Research Center, Portland, OR, USA. · Dermatologikum Hamburg and SCIderm GmbH, Hamburg, Germany. · NorthShore University Health System, Skokie, IL, USA. · Dermatology Department, Hospital Universitario, Madrid, Spain. · Department of Medicine (Dermatology) UCLA, Los Angeles, CA, USA. · Baylor University Medical Center, Dallas, TX, USA. · Formerly with Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Novartis Pharma AG, Basel, Switzerland. · RTI Health Solutions, Research Triangle Park, NC, USA. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · University of Texas Health Science Center for Clinical Studies, Houston, TX, USA. · Pubmed 28602039
  • SCIderm Research Institute and Dermatologikum Hamburg, Hamburg, Germany. Electronic address: · Probity Medical Research, Waterloo, ON, Canada. · Oregon Medical Research Center, Portland, OR, USA. · Department of Dermatology, University of Texas Health Science Center, Houston, TX, USA. · Epworth Hospital Department of Dermatology, University of Melbourne, Melbourne, VIC, Australia. · Comprehensive Center for Inflammation Medicine, University Medical School Schleswig-Holstein, University of Lübeck, Lübeck, Germany. · Merck & Co, Kenilworth, NJ, USA. · Harvard Medical School, Boston, MA, USA. · Pubmed 28596043
  • From K. Papp Clinical Research and Probity Medical Research, Waterloo, ON (K.A.P.), School of Medicine, Queen's University, Kingston, ON (M.G.), and Centre for Dermatology and Probity Medical Research, Peterborough, ON (M.G.) - all in Canada · Oregon Medical Research Center, Portland (A.B.) · Altman Dermatology Associates, Arlington Heights, IL (M.B.) · Rockefeller University, New York (J.K.) · Hôpital de l'Archet, University of Nice-Sophia Antipolis, Nice, France (J.-P.L.) · Baylor Research Institute, Dallas (A.M.) · Charité Universitätsmedizin Berlin, Berlin (S.P.), Boehringer Ingelheim Pharma, Biberach (B.R.B.), and Boehringer Ingelheim Pharma, Ingelheim, (S.J.P.) - all in Germany · University of Texas Health Science Center, Houston (S.T.) · University of California, Los Angeles, School of Medicine, Los Angeles (H.S.) · and Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (S.V., C.P., N.B., M.F., P.S.). · Pubmed 28423301
  • Psoriasis Treatment Center of Central New Jersey, East Windsor, NJ, U.S.A. · University of Texas Health Science Center and Center for Clinical Studies, Houston, TX, U.S.A. · Amgen Inc., Thousand Oaks, CA, U.S.A. · Probity Medical Research, Ontario, Canada. · Pubmed 28196270
  • a University Hospitals Cleveland Medical Center , Cleveland , OH , USA. · b Department of Medicine/Dermatology , University of California at Los Angeles , Los Angeles , CA , USA. · c Dawes Fretzin Dermatology Group , Indianapolis , IN , USA. · d Oregon Dermatology and Research Center , Portland , OR , USA. · e Novartis Pharmaceuticals Corporation , One Health Plaza , East Hanover , NJ , USA. · f RTI Health Solutions , Research Triangle Park , NC , USA. · g RTI Health Solutions , Ann Arbor , MI , USA. · h Department of Dermatology , University of Texas Health Science Center , Houston , TX , USA. · Pubmed 27832717
  • Oregon Medical Research Center, Portland, Oregon. Electronic address: · Dermatologikum Hamburg and SCIderm Research Institute, Hamburg, Germany. · National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. · University of Texas Health Science Center at Houston, Center for Clinical Studies, Houston, Texas. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Dermatology Clinic, Tartu University Hospital, Tartu, Estonia. · Emek Medical Center, Afula, Israel. · Goethe Universität Frankfurt am Main, Frankfurt, Germany. · McMaster University, Hamilton, Ontario, Canada. · Novartis Pharma AG, Basel, Switzerland. · Novartis Beijing Novartis Pharma Co. Ltd, Shanghai, China. · Comprehensive Center for Inflammation Medicine, University Hospital Schleswig-Holstein, Lübeck, Germany. · Pubmed 27663079
  • Oregon Health and Science University, Portland, Oregon. Electronic address: · Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York. · Department of Quality Measures and Research, Clalit Health Services, Tel Aviv, Israel; Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel. · University of Texas Health Science Center, Houston, Texas. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, Collegeville, Pennsylvania. · Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Hellerup, Denmark. · Pfizer Inc, New York, New York. · Pubmed 28711084
  • Oregon Medical Research Center, Portland, OR, U.S.A. · Dermatologikum Hamburg and SCIderm Research Institute, Hamburg, Germany. · The Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, U.K. · Department of Dermatology, Venereology, and Allergology, Wroclaw Medical University, Wroclaw, Poland. · Department of Dermatology, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · University of Texas Health Science Center at Houston and Center for Clinical Studies, Houston, TX, U.S.A. · Novartis Pharma AG, Basel, Switzerland. · Novartis Healthcare Pvt. Ltd, Hyderabad, India. · Dalhousie University, Halifax, NS, Canada. · Pubmed 28498514
2016
  • Center for Clinical Studies, Houston, TX, USA. · Baylor College of Medicine, Houston, TX, USA. · Department of Dermatology, University of California San Diego, San Diego, CA, USA. · Department of Dermatology, University of Texas Health Science Center at Houston, Houston, TX, USA. · Center for Clinical Studies, Houston, TX, USA; Department of Dermatology, University of Texas Health Science Center at Houston, Houston, TX, USA. · Pubmed 27825174
  • a Department of Dermatology , University of California , San Francisco , San Francisco , CA , USA . · b Department of Dermatology , University of Texas Health Science Center , Houston , TX , USA . · c University of Washington School of Medicine , Seattle , WA , USA . · d Suzanne Bruce and Associates, PA , Houston , TX , USA . · e LEO Pharma A/S , Ballerup , Denmark , and. · f Psoriasis Treatment Center of Central New Jersey , East Windsor , NJ , USA. · Pubmed 26444907
  • Probity Medical Research and K. Papp Clinical Research Inc, Waterloo, Ontario, Canada. · Rockefeller University, New York, New York. · Wake Forest Baptist Health, Winston-Salem, North Carolina. · Dalhousie University, Halifax, Nova Scotia, Canada. · Comprehensive Center for Inflammation Research, University Hospital Schleswig-Holstein Campus Lübeck, Lübeck, Germany. · Division of Dermatology, Tokyo Yamate Medical Center, Tokyo, Japan. · Department of Dermatology, University of Texas Medical School, Houston, Texas. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, Cambridge, Massachusetts. · Dermatology Unit, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. · Pfizer Inc, Groton, Connecticut. Electronic address: · Pubmed 26899199
2015
  • Department of Dermatology, University of Maryland Medical Center, Baltimore, Maryland. · Department of Dermatology, University of Texas Health Science Center, Houston, Texas. · Pubmed 26201310
  • From the Icahn School of Medicine at Mount Sinai, New York (M.L., L.K.) · University of Connecticut School of Medicine, Farmington (B.S.) · Probity Medical Research (B.S., L.S., D.T.) and XLR8 Medical Research (D.T.), Windsor, ON, K Papp Medical Research (K.P.), Waterloo, ON, and Dalhousie University, Halifax, NS (R.G.L.) - all in Canada · Baylor University Medical Center, Dallas (A.M.) · Northwestern University, Feinberg School of Medicine, Chicago (K.G.) · Niepubliczny Zakład Opieki Zdrowotnej multiMedica, Wrocław (J.W.), and Lubelskie Centrum Diagnostyczne, Świdnik (T.B.) - both in Poland · Hospital de la Santa Creu i Sant Pau, Barcelona (L.P.) · Veracity Clinical Research, Woolloongabba, QLD, Australia (L.S.) · Florida Academic Dermatology Center, Miami (F.K.) · University of Colorado, Denver (A.W.A.) · Medizinische Universität Wien, Vienna, Austria (G.S.) · Massachusetts General Hospital and Harvard Medical School, Boston (A.B.K.) · Sorbonne Paris Cité Université Paris Diderot, Assistance Publique-Hôpitaux de Paris Hôpital Saint Louis, Paris (H.B.), Paul Sabatier University, Toulouse (C.P.), and University Hospital of Nice, Nice (J.-P.L.) - all in France · Kaiser Permanente Los Angeles Medical Center, Los Angeles (J.J.W.), Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield (J.C.), University of California, San Francisco, San Francisco (J.K.), and Amgen, Thousand Oaks (G.A., J.L., W.S., C.E.M., Y.S., N.E., P.K., B.K., A.N.) - all in California. · University of Texas Health Science Center, Houston (S.T.) · DermResearch, Louisville, KY (L.K.) · University of Rome Tor Vergata, Rome (S.C.) · University of Utah Medical Center, Salt Lake City (K.C.D.) · and the Psoriasis Treatment Center of Central New Jersey, East Windsor (J.B.). · Pubmed 26422722
  • Department of Dermatology, Faculty of Medicine, University of Chile and Probity Medical Research, Santiago, Chile. · Clinical Research and Probity Medical Research, Waterloo, ON, Canada. · Department of Dermatology, Eastern Virginia Medical School and Virginia Clinical Research Inc., Norfolk, VA, USA. · Department of Dermatology, University of Texas Medical School, Houston, TX, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, Groton, CT, USA. · Quintiles, Cambridge, MA, USA. · Present address: Statistical Consulting & Solutions, LLC, Brookline, MA, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, New York, NY, USA. · Specialty Care Medicines Development Group, Pfizer Inc, 219 E 42nd Street, 7th Floor Room 50, NYO 219/07/01, New York, NY, 10017, USA. · Pubmed 25951857
2014
  • From Dalhousie University, Halifax, NS (R.G.L.), Clinical Research (K.P.) and Probity Medical Research (K.P., L.S.), Waterloo, ON, and Stratica Medical and Probity Medical Research, Edmonton, AB (N.W.) - all in Canada · University of Alabama, Birmingham (B.E.E.) · Mount Sinai Hospital, New York (M.L.) · Dermatologikum Hamburg and Georg-August-Universität, Göttingen, Germany (K.R.) · Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom (C.E.M.G.) · Hospital de Sant Pau, Barcelona (L.P.) · Jikei University School of Medicine, Tokyo (H.N.) · Veracity Clinical Research, Woolloongabba, QLD, Australia (L.S.) · Faculty of Medicine, Department of Dermatology, University of Iceland, Reykjavik (B.S.) · Dermos, Guatemala City, Guatemala (E.R.) · Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei (T.-F.T.) · University of Texas Health Science Center and Center for Clinical Studies, Houston (S.T.) · and Novartis Pharma, Basel, Switzerland (T.S., I.H., M.N., A.K., S.H., C.P.). · Pubmed 25007392
2010
  • Center for Clinical Studies, Department of Dermatology, University of Texas Health Science Center, Houston, TX, USA. · Pubmed 20964660
2008
  • Center for Clinical Studies and Department of Dermatology, University of Texas Health Science Center, Houston, TX 77030, USA. · Pubmed 18486724
Miscellaneous institutions in Houston
2015
  • Center for Clinical Studies, Houston, TX, USA. · Department of Dermatology, University of Texas Health Science Center at Houston, Houston, TX, USA. · Pubmed 25807335
2013
2008
  • Center for Clinical Studies, 6655 Travis #120, Houston, TX 77030, USA. · Pubmed 18363545
  • Center for Clinical Studies, Houston, TX, USA. · Pubmed 19145382
3 Other Locations Show
Yearly article counts 0010344222103
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.